Maxi Investments CY Ltd Buys New Stake in Astera Labs, Inc. $ALAB

Maxi Investments CY Ltd bought a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) in the fourth quarter, HoldingsChannel.com reports. The firm bought 9,500 shares of the company’s stock, valued at approximately $1,580,000.

A number of other hedge funds also recently bought and sold shares of the company. Nordea Investment Management AB bought a new stake in Astera Labs during the 4th quarter valued at approximately $2,028,000. Geneva Partners LLC bought a new position in Astera Labs in the 3rd quarter worth approximately $1,876,000. Numerai GP LLC increased its position in Astera Labs by 153.1% in the 3rd quarter. Numerai GP LLC now owns 13,212 shares of the company’s stock worth $2,587,000 after buying an additional 7,992 shares during the period. Handelsbanken Fonder AB lifted its holdings in shares of Astera Labs by 289.5% during the third quarter. Handelsbanken Fonder AB now owns 126,200 shares of the company’s stock worth $24,710,000 after buying an additional 93,800 shares during the last quarter. Finally, Paragon Advisors LLC acquired a new position in shares of Astera Labs during the third quarter worth approximately $1,829,000. 60.47% of the stock is currently owned by institutional investors.

Astera Labs Trading Down 8.5%

Shares of NASDAQ ALAB opened at $195.65 on Friday. The business has a fifty day simple moving average of $143.77 and a 200 day simple moving average of $153.99. The firm has a market capitalization of $33.51 billion, a price-to-earnings ratio of 132.20, a PEG ratio of 4.21 and a beta of 3.35. Astera Labs, Inc. has a one year low of $69.26 and a one year high of $262.90.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. The firm had revenue of $308.36 million for the quarter, compared to the consensus estimate of $292.19 million. Astera Labs had a net margin of 26.72% and a return on equity of 19.36%. The business’s revenue was up 93.5% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, research analysts anticipate that Astera Labs, Inc. will post 1.48 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on ALAB shares. Weiss Ratings upgraded shares of Astera Labs from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday. Citigroup increased their price target on shares of Astera Labs from $200.00 to $245.00 and gave the company a “buy” rating in a report on Wednesday. UBS Group began coverage on shares of Astera Labs in a report on Tuesday, April 21st. They set a “neutral” rating and a $180.00 price objective on the stock. Royal Bank Of Canada upped their price objective on shares of Astera Labs from $250.00 to $270.00 and gave the company an “outperform” rating in a research report on Wednesday. Finally, Barclays increased their target price on shares of Astera Labs from $165.00 to $200.00 and gave the company an “equal weight” rating in a research note on Thursday. Fifteen analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $229.65.

Insider Activity at Astera Labs

In other news, COO Sanjay Gajendra sold 94,971 shares of Astera Labs stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price of $123.81, for a total transaction of $11,758,359.51. Following the sale, the chief operating officer directly owned 1,531,301 shares in the company, valued at approximately $189,590,376.81. The trade was a 5.84% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Jitendra Mohan sold 325,693 shares of the company’s stock in a transaction dated Friday, April 17th. The shares were sold at an average price of $172.14, for a total transaction of $56,064,793.02. Following the completion of the sale, the chief executive officer directly owned 4,079,322 shares in the company, valued at approximately $702,214,489.08. The trade was a 7.39% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 1,064,888 shares of company stock worth $150,764,723 in the last ninety days. Company insiders own 12.50% of the company’s stock.

Key Headlines Impacting Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Q1 results materially beat expectations — revenue nearly doubled, EPS beat, gross margins expanded and management raised Q2 guidance; company highlighted strong PCIe?6 and AI connectivity demand (Scorpio/X-series momentum). ALAB Q1 Earnings Beat
• Positive Sentiment: Multiple brokerages raised targets/ratings this week (JPMorgan to $280/Overweight; Needham and Stifel to $260; Susquehanna raised target) — institutional research is now more bullish, giving the stock additional upside case. JPMorgan Boost Needham Raise
• Positive Sentiment: Analyst/commentary pieces emphasize Astera’s strategic position in AI/datacenter internal connectivity and a strong product roadmap (X?series, optical plans) that should support multi?year growth. MarketBeat: AI Connectivity Seeking Alpha Q1 Take
• Neutral Sentiment: Earnings-call detail and transcripts are available for investors wanting depth on product cadence, gross?margin outlook and inventory comments. Earnings Call Transcript
• Neutral Sentiment: Market coverage summaries and headlines captured the post?earnings momentum but reflect a fast-moving narrative that can flip with short-term flows. TipRanks Highlights MarketWatch
• Negative Sentiment: Valuation and risk concerns: analysts and commentaries warn that ALAB now trades at a premium (high P/E and PEG) and that rising costs, competition and execution risk could limit upside — a common reason for short?term selling or profit-taking. Zacks Caution
• Negative Sentiment: Third?party pieces question whether the recent run-up has left the stock stretched relative to fundamentals, which increases the risk of a pullback on heavy volume. Yahoo: Overvaluation

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.